SODIUM SUCCINATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for sodium succinate and what is the scope of patent protection?
Sodium succinate
is the generic ingredient in one branded drug marketed by Elkins Sinn and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for sodium succinate.
Summary for SODIUM SUCCINATE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Clinical Trials: | 35 |
Patent Applications: | 6,342 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SODIUM SUCCINATE at DailyMed |
Recent Clinical Trials for SODIUM SUCCINATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Maastricht University Medical Center | Phase 3 |
Gelre Hospitals | Phase 3 |
ZonMw: The Netherlands Organisation for Health Research and Development | Phase 3 |
US Patents and Regulatory Information for SODIUM SUCCINATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Elkins Sinn | SODIUM SUCCINATE | sodium succinate | INJECTABLE;INJECTION | 080516-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |